Methionine-pyridoxine and airsickness
By: Harry H. Malvin, Major, USAF, MC
Contributors: Julio Mario Santo Domingo Collection; USAF School of Aerospace Medicine
Publisher: USAF School of Aerospace Medicine
Published: 1966
Place of publication: Brooks Air Force Base, Texas
Language: eng
Subjects: Motion sickness; Prevention; Methionine; Therapeutic use; Vitamin B6; Motion Sickness; Prevention & control; Pyridoxine
Description: The paper presents two observations made incidental to a series of unsuccessful experiments which were designed to study individual variation of response to stimuli intended to induce airsickness. The first observation suggests that capsules containing 50 mg. 1-methionine and 50 mg. pyridoxine, when administered initially and midway during a 4-hour flight, have a limited ability to protect human volunteers against motion sickness. The second observation identifies a structural similarity between the therapeutically effective antimotion sickness agents, neurochemical transmitters, and the peptide linkage.
Notes: Report no. 66-87.

"October 1966."

Includes bibliographical references.